Gemcitabine, 2'-deoxy-2',2'-difluorocytidine, is currently prescribed against a number of cancers. Here we report a linear synthesis of gemcitabine with a high-yielding direct conversion of 3,5-di-O-benzoyl-2-deoxy-2,2-difluororibose into the corresponding glycosyl urea as the key step, followed by conventional conversion to the cytosine base via the uracil derivative. The process proceeded with modest anomeric selectivity.
Introduction
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Gemcitabine 1 (Scheme 1), marketed by its discoverer Lilly as the HCl salt under the trade name of Gemzar, is a widely prescribed anticancer drug against pancreatic, ovarian and breast cancer. Before its recent patent expiry, it was a $1 bn dollar per annum drug, and while sales have now dropped below that figure, its market continues to grow. It is a fluorinated nucleoside [1] [2] [3] [4] [5] [6] prodrug, undergoing intracellular phosphorylation to its active diphosphate and triphosphate form, which inhibits DNA synthesis leading to apoptosis.
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Scheme 1: Convergent nucleobase introduction in the synthesis of gemcitabine 1.
The synthesis of gemcitabine 12 has been subject to tremendous and -spurred by the Lilly patent expiry-still continuing efforts. 13 In general, a convergent synthesis has been applied, in which a suitably protected and activated 2-deoxy-2,2-difluororibofuranose derivative 2 (Scheme 1) is combined with an activated cytosine base, eg 3. Much optimisation has been devoted to an efficient 2-deoxy-2,2-difluororibofuranose synthesis, a feat which has now largely been achieved through use of specific alcohol protecting groups allowing efficient and high-yielding diastereomer separation by crystallisation(s). The nucleobase introduction reaction has also been subject to intensive research. This process is made difficult by the difluorination at the sugar 2-position, and typically leads to an anomeric mixture.
Again, selective crystallisation procedures have been developed to obtain anomerically pure gemcitabine. 
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
While alternative linear nucleoside syntheses are common in the carbanucleoside field, [14] [15] [16] this strategy has to our knowledge been applied only once for the gemcitabine synthesis (Scheme 2a).
17
Scheme 2. Linear gemcitabine synthesis.
Here the sugar donor 5 was reacted with the N-2-cyanovinyl amide 4 to give the intermediate 6, after which the cytosine synthesis was completed by base-induced
cyclisation. An overall yield of 12% was reported. A linear synthesis is also possiblebut not reported -from the corresponding amino-2-deoxy-2,2-difluoroglycoside 9, which has been synthesised in two steps by a Lilly group. 18 (Scheme 2b). However, while 9 was obtained in high yield, no anomeric selectivity was obtained, and the anomeric ratio of 9 was independent of the anomeric ratio of the azide precursor 8,
suggesting an equilibration process.
Herein we describe our efforts leading to an alternative linear gemcitabine synthesis.
In order to avoid the abovementioned anomerisation at the aminoglycoside stage, a nucleobase construction strategy starting from the corresponding glycosyl urea 10 was envisioned (Scheme 3). It was hoped that the possible crystallinity of this urea derivative would offer anomeric purification prospects. In addition, it was planned to introduce the urea by a direct condensation reaction with the known 3,5-di-O-benzoyl-2-deoxy-2,2-difluororibose 11, thus bypassing the need for anomeric activation. This protected difluororibose derivative was first described by a Lilly group, 19 but obtained by us by reduction of the commercially available dibenzoylated difluororibonolactone.
Results and discussion
Urea condensation
The work commenced by investigating the direct urea introduction. The acidcatalysed condensation of aldehydes with urea has been reported in high yields, 20, 21 and there were few reports available of this process with unprotected (and unfluorinated) carbohydrates. 22, 23 In recent years, the reaction of unprotected and non-activated carbohydrates with ureas has received renewed attention, and has typically been achieved with an acid-catalyst. 24 Hence, it was first investigated whether the acid-catalysed condensation of a difluorinated sugar such as furanose 11 was possible with ureas. Initially, the 5-O-TBDPS lactol 12 was used as substrate (Table 1) , and to avoid complication by the urea reacting at both ends, N,N-dimethyl urea 12 was used. M A N U S C R I P T
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[a] Isolated yield. [b] Remove reaction solvent by evaporation in vacuo. [c] Filtration over silica. [d] Filtration over celite.
[e] 2.3 mmol scale.
Reaction of 12 with 13b using a variety of acid catalysts (TMSOTf, Ti(Oi-Pr) 4 , 4 N HCl, AcOH, TFA, p-TsOH) in a range of solvents (THF, DCM, toluene, trifluoroethanol, hexafluoroisopropanol) all gave no or only trace amounts of product 14 (not shown), except the combination of p-TsOH and toluene at reflux (entry 1).
While, when using 2 equiv of urea the presence/absence of molecular sieves had no significant influence (entries 1,2), when 1 equiv of urea was used, the use of molecular sieves did lead to a higher yield (entries 3,4). Due to the possible lability of 
the TBDPS ether in acidic medium, further optimisation experiments were carried out with the 3,5-di-O-benzoyl-2-deoxy-2,2-difluororibose 11, obtained by reduction of the commercially available lactone. Indeed, reaction with 13b now gave a much improved 65% yield (entry 5), although a further increase in amount of urea was used. At this stage, it was decided to investigate the non-methylated urea 13a, which turned out to be unproblematic with regard to a sequential condensation process.
The best solvent proved to be 1,4-dioxane (entry 6), giving a yield of 40%, with 39% recovered starting material, when using 1 equiv of p-TsOH. An increase in the relative amount of urea increased the yield to 59% (entry 7). As good conversion was seen by NMR analysis of crude material, losses during the workup due to difficult filtration of the molecular sieves were thought to be responsible for the reduced yield.
However, a change of drying agent to Na 2 SO 4 (entries 8-11), whilst facilitating the work-up, did not have a significant effect upon the yield, regardless of urea stoichiometry. Changing the workup to filtration over celite instead of silica gel did improve the yield (entry 12), though, surprisingly, the reaction without Na 2 SO 4 worked equally well (entry 13). Increasing the number of urea equivalents to 5 had no further beneficial effect (entry 14). Finally, reaction on 2.3 mmol scale under the best conditions led to an excellent 88% yield (entry 15) of the glycosyl ureas in a 1:1.8 anomeric ratio. Unfortunately, assignment of the anomers could not be achieved.
Formation of the cytosine nucleobase
Next, acylation of the urea group with acyl chloride 16, synthesised by the method of Tietze, 25 to give the nucleobase cyclisation precursor was investigated. Interestingly, this glycosyl urea acylation does not have a precedent for O-nucleosides, but has been demonstrated with carbanucleosides using pyridine with DMAP. 26, 27 However, reaction of 14a with 16 under those conditions ( Table 2 , entry 1), only afforded 30% of the desired product 17. Unexpectedly, significant anomerisation was observed,
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which led to a decrease in anomeric ratio (1:2.4 to 1:1). This anomerisation may be due to urea deprotonation by pyridine (Scheme 4), facilitated by the electron withdrawing fluorines at the 2-position, to give the conjugate base 18. Anomerisation can then be envisaged by ring opening to 19 followed by non-selective ring closure.
Scheme 4. Possible anomerisation mechanism
Thus, the basic pyridine solvent was replaced by DCM, but even with 1 equiv of DMAP, none of the desired product was observed after 3.5 d (entry 2). Pleasingly, refluxing in acetonitrile with 2 equiv of 16 (entry 3) did yield the product in 45% yield, with a further improvement to 71% seen when the amount of 16 was increased to 4 equiv (entry 4). These conditions also resulted in less anomerisation (1:2.4 to 1:1.5). The same conditions with 1,4-dioxane as solvent gave a slightly lower yield, but more anomerisation was observed (entry 5). The least anomerisation was seen when ZnCl 2 was employed, with a 1:1.9 anomeric ratio seen in the isolated product (entry 6), but a lower yield was obtained. [a] isolated yield. [b] Determined by NMR analysis on the crude reaction mixture.
Scheme 5.
Conversion to gemcitabine 1 via the corresponding uridine 20.
With the acyl carbamate 17 in hand, cyclisation to the protected difluorouridine 20 was studied (Scheme 5) using methodology originally developed by Shaw. 28 Among the various acidic protocols screened, HCl/AcOH emerged as the most efficient, leading to quantitative conversion to 20 in a 1:1.2 α/β mixture. Next, conversion of uridine to cytidine was effected using described methodology 29, 30 via the triazole intermediate 21 by treatment with 2-chlorophenyl phosphorodichloridate and 1,2,4-triazole in pyridine, followed by reaction with ammonia. The ammonia treatment also caused concomitant benzoate deprotection, which then furnished gemcitabine 1 as a 1:1.3 mixture of α:β anomers.
Conclusion
The linear synthesis of gemcitabine was achieved in 5 steps from a 2-deoxy-2,2-difluororibose substrate with moderate anomeric selectivity. The demonstration of a high-yielding direct glycosyl urea formation through reaction of a reducing 2-deoxy-2,2-difluorinated sugar derivative with urea will be of interest for other applications. were distilled from sodium/benzophenone ketyl; DCM, pyridine and Et 3 N were distilled from CaH 2 ; toluene was distilled from Na; MeCN was dried over 3 Å molecular sieves. Reaction vessels were flame dried under vacuum and cooled under N 2 prior to use and all experiments were carried out under a N 2 atmosphere.
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All other reagents were purchased from commercial sources and used without further purification. 
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